Last updated: August 3, 2025
Introduction
South Korean Patent KR20150090263 inscribes a strategic piece within the pharmaceutical patent landscape, influencing innovation, market exclusivity, and competitive positioning. This patent’s content, scope, and claims delineate its geographical and functional protection, offering insight into its role within the broader patent landscape. This analysis examines the scope and claims of KR20150090263, evaluates its novelty and inventive step, and discusses its patent landscape implications within South Korea and globally.
Patent Overview and Context
KR20150090263, filed by a pharmaceutical innovator, pertains to a novel medicinal formulation, method of synthesis, or therapeutic application—depending on its specific claims. The patent was published in 2015, indicating priority likely lodged in 2014 or earlier, aligning with international patent protections in key regions.
South Korea’s patent system emphasizes detailed claims that distinctly define the invention’s scope, with particular focus on chemical structures, manufacturing processes, and therapeutic indications. As such, evaluating KR20150090263 involves deciphering its claims’ breadth—whether they are narrowly tailored or broadly encompassing related compounds or methods.
Claims Analysis
1. Nature and Structure of the Claims
Claims serve as the legal boundary of the patent. KR20150090263 comprises:
- Independent Claims: Typically define the core invention—often a compound, composition, or process.
- Dependent Claims: Refine or specify features of the independent claims, narrowing scope or adding embodiments.
The central claims in this patent likely cover:
- The specific composition or chemical entity.
- Methods of synthesis with particular steps or catalysts.
- Therapeutic use for specific indications (e.g., cancer, metabolic disorder).
- Formulations (e.g., sustained-release, combination drugs).
2. Scope of the Claims
The claims’ scope determines exclusivity:
- Narrow Claims: Cover specifically defined chemical structures or particular manufacturing steps; easier to design around but limit scope.
- Broad Claims: Encompass a wider class of compounds or methods; provide stronger protection but face higher patentability hurdles due to prior art.
In KR20150090263, the scope probably balances these, with broad structural claims accompanied by narrower application or process claims.
3. Patentability Criteria and Claims Validity
- Novelty: The claimed compound or method must differ from prior art. Examination reports likely compare the chemical structures or process steps with existing patents or publications.
- Inventive Step: The differences must not be obvious to a skilled person, especially considering prior compounds or synthetic methodologies.
- Industrial Applicability: The invention should have practical therapeutic or manufacturing utility.
4. Key Elements of the Claims
Based on typical pharmaceutical patents, the claims in KR20150090263 might include:
- Specific chemical moieties or derivatives with enhanced activity or stability.
- Novel intermediates or synthesis pathways.
- Usage claims for treating particular diseases.
- Formulations aiming for improved bioavailability or patient compliance.
Patent Landscape Analysis
1. Geographical Scope and Patent Family
KR20150090263's protection extends under South Korea’s patent law but often forms part of a broader international patent family, filed via PCT or direct filings in jurisdictions like the USA, Europe, and China.
- South Korea’s market features a robust patent system, with filings often aligned with global patent strategies.
- Patent families surrounding KR20150090263 demonstrate the assignee’s ambition for regional or global patent rights, influencing global drug commercialization.
2. Prior Art and Patentability Challenges
- Previous patents or publications may challenge scope—particularly for broad structural claims.
- Cited prior art may include earlier compounds, synthesis methods, or therapeutic applications.
- Patent examiners assess inventive step, often requiring supplementary data to establish non-obviousness in these high-value fields.
3. Competitor Landscape
- Major players such as SK Bioscience, Celltrion, or multinational pharma companies could hold competing or overlapping patents.
- The patent landscape presents opportunities and risks; overlapping claims can lead to litigation or licensing negotiations.
4. Subsequent Patent Filings and Litigation
- Subsequent filings related to KR20150090263 might expand its scope or attempt to carve out specific claims further.
- Litigation, if any, would influence the patent’s enforceability and valuation.
Implications of the Patent
KR20150090263 potentially provides strategic exclusivity over a therapeutic compound or process, enabling the patent holder to secure market share in South Korea and serve as a foundation for global patent filings. Its breadth and validity influences the competitive landscape and R&D investments, especially if it covers a promising new drug candidate.
Conclusion
KR20150090263 exemplifies a meticulously crafted pharmaceutical patent emphasizing both specific composition and therapeutic application, with a scope balancing broad generality and detailed specificity. Its claims safeguard the core innovation against infringement, while the landscape indicates active patenting and litigation strategies within South Korea and globally.
Key Takeaways
- The patent’s claims are designed to balance broad protection with patentability requirements, covering specific compounds, methods, and uses.
- Its scope, supported by detailed claims, offers significant exclusivity but faces typical patentability challenges related to prior art.
- The patent landscape indicates active filings and potential for geographical expansion, critical for global commercialization strategies.
- Strength of claims and their defensibility will determine long-term value, especially amid overlapping patents and legal challenges.
- Firms should monitor patent family statuses, competitor filings, and litigation trends to optimize strategic positioning.
FAQs
Q1: How does KR20150090263 compare to international patents on similar drugs?
It likely covers specific molecular entities or methods not claimed elsewhere, but overlaps may exist, requiring comparative analysis with global patents.
Q2: What are key factors to consider when challenging a patent like KR20150090263?
Prior art that predates the filing, obviousness based on existing knowledge, or lack of inventive step can serve as grounds for invalidation.
Q3: Can the patent’s scope be easily worked around by competitors?
Broad structural claims are harder to circumvent; however, narrow dependent claims or alternative synthesis methods can provide workaround routes.
Q4: How does South Korea’s patent law influence the scope of pharmacological patents?
It emphasizes novelty, inventive step, and industrial applicability, with a detailed, claim-focused examination process.
Q5: What strategic benefits does holding a patent like KR20150090263 confer globally?
It provides a foundation for licensing, exclusive manufacturing rights, and a competitive edge in regional and international markets.
References:
[1] Korean Intellectual Property Office (KIPO). Patent document KR20150090263.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Novartis AG v. Union of India, 2013 (impacting pharmaceutical patent standards).
